You are here

  • Home
  • Archive
  • Volume 2, Issue Suppl 3
  • Evidence for a coordinate role of CD14+ antigen-presenting cells and regulatory T cells in conditioning the microenvironment of metastatic lymph nodes from patients with cervical cancer

Article Text

Article menu

Download PDFPDF

Poster Presentation
Evidence for a coordinate role of CD14+ antigen-presenting cells and regulatory T cells in conditioning the microenvironment of metastatic lymph nodes from patients with cervical cancer
  1. Marijne Heeren1,
  2. Bas Koster2,
  3. Sanne Samuels3,
  4. Debbie Ferns1,
  5. Dafni Chondronasiou2,
  6. Gemma Kenter1,
  7. Ekaterina S Jordanova1 and
  8. Tanja D de Gruijl2
  1. Aff1 grid.16872.3a000000040435165XObstetrics & GynecologyVU University Medical Center Amsterdam The Netherlands
  2. Aff2 grid.16872.3a000000040435165XMedical OncologyVU University Medical Center Amsterdam The Netherlands
  3. Aff3 grid.430814.aGynecology, The Netherlands Cancer Institute Amsterdam The Netherlands

https://doi.org/10.1186/2051-1426-2-S3-P211

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Meeting abstracts

    A better understanding of the microenvironment in relation to lymph node metastasis is essential for the development of effective immunotherapeutic strategies against cervical cancer.

    In the present study, we investigated the microenvironment of tumor-draining lymph nodes of cervical cancer patients, by comprehensive flow cytometry-based phenotyping and enumeration of immune-cell subsets in tumor-negative (LN-, n = 20) versus tumor-positive lymph nodes (LN+, n = 8), and by the study of cytokine release profiles (n = 4 for both LN- and LN+).

    We found significantly lower CD4+ and higher CD8+ T-cell frequencies in LN+ samples, accompanied by increased surface levels of activation (HLA-DR and ICOS) and inhibitory markers (PD-1 and CTLA-4). Furthermore, in LN+ we found increased rates of a potentially regulatory antigen-presenting cell (APC) subset (CD11chiCD14+PD-L1+) and of myeloid-derived suppressor cell (MDSC) subsets, which in the case of the former correlated significantly with elevated frequencies of FoxP3+ Tregs. After in vitro stimulation with different TLR ligands (PGN; Poly-IC; R848), we observed higher production levels of IL-6, IL-10 and TNFα but lower levels of IFNγ in LN+.

    We conclude that, despite increased T-cell differentiation and activation, a striking switch to a profound immune suppressive microenvironment in LN+ of cervical cancer patients will enable immune escape. Our data point to the CD14+PD-L1+ APC/Treg axis as a particularly attractive and relevant therapeutic target to specifically tackle microenvironmental immune suppression and thus enhance the efficacy of immunotherapy in patients with metastasized cervical cancer.